English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

We report 2 patients who received medical guidance during immunosuppressive therapy involving the administration of antithymocyte globulin (ATG) and cyclosporin A (CyA) for complicated aplastic anemia. In case 1, during the second administration of ATG, side effects manifested as allergic reaction and serum sickness. In case 2, the side effects after the first administration of ATG were the same as those in case 1. An antimycotic drug that can increase the blood concentration of CyA was also administered in case 1. The BUN level, which is a marker of renal function, was slightly elevated. In both cases, drug compliance for CyA was good, and the trough blood concentration of CyA remained within the objective concentration. Levels of leucocyte, neurophils and thrombocytes tended to the recover after combined administration of both drugs in the 2 patients. However, the patient's quality of life (QOL) decreased remarkably due to a deterioration of the stomatitis, since the host was immunocompromised. The patient's QOL improved by the administration of narcotic analgesics. In case 2, the stomatitis did not worsen, since infection was prevented by the use of a clean room and care of the oral cavity. This study suggests that appropriate pharmaceutical care during immunosuppressive therapy contributes to QOL maintenance in patients with aplastic anemia.

Immunosuppressive Therapy wit Medication Guidance in Complicated Aplastic Anemia Patients-A Case Study-